abstract |
The invention concerns cyclopentane ether derivatives of formula (I), their salts with physiologically tolerable bases, as well as the α, β- and η-cyclodextrin clathrates and compounds of formula (I) encapsulated with liposomes. The invention also concerns methods for preparing these compounds and their use in pharmaceuticals. |